Ginkgo Bioworks Holdings, Inc. (DNA)

Ginkgo Bioworks Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	686	459	504	3,382	3,197	13,391
Market Cap Growth	31.08%	-9.05%	-85.09%	5.78%	-76.12%	-
Enterprise Value	708.78	453.23	381.61	2,660	2,295	11,925
Last Close Price	10.50	8.31	9.82	67.60	67.60	332.40
PS Ratio	4.44	2.70	2.22	13.45	6.69	42.67
PB Ratio	1.43	0.90	0.70	3.08	1.84	8.90
P/TBV Ratio	1.51	1.01	0.79	3.41	1.81	7.73
EV/Sales Ratio	4.68	2.66	1.68	10.58	4.80	38.00
Debt / Equity Ratio	0.93	0.82	0.61	0.20	0.24	0.01
Net Debt / Equity Ratio	0.08	-0.01	-0.17	-0.66	-0.52	-1.01
Net Debt / EBITDA Ratio	-0.15	0.02	0.25	0.91	0.42	0.85
Net Debt / FCF Ratio	-0.22	0.03	0.32	2.15	2.96	4.92
Asset Turnover	0.11	0.14	0.15	0.12	0.21	0.23
Inventory Turnover	-	-	-	-	121.49	42.54
Quick Ratio	4.95	4.66	5.44	5.87	8.08	12.51
Current Ratio	5.15	4.92	5.62	6.11	8.38	12.79
Return on Equity (ROE)	-79.95%	-51.08%	-60.34%	-63.02%	-127.52%	-180.29%
Return on Assets (ROA)	-27.56%	-25.18%	-36.76%	-41.11%	-95.15%	-133.06%
Return on Invested Capital (ROIC)	-60.34%	-57.36%	-115.53%	-143.02%	-502.24%	-2512.51%
Return on Capital Employed (ROCE)	-30.11%	-27.49%	-40.39%	-44.70%	-102.68%	-144.08%
Buyback Yield / Dilution	-7.29%	-6.87%	-6.76%	-15.75%	-23.48%	-6.72%
Total Shareholder Return	-7.29%	-6.87%	-6.76%	-15.75%	-23.48%	-6.72%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error